Gilead Trades at 13x. AbbVie Just Raised Guidance Again. One Is Priced Wrong.
Two biopharma giants sitting at opposite ends of the market’s attention span.
Category: Money
Micron Just Had the Best Quarter in Its History. The Stock Is Down.
Record earnings, sold-out supply, and a $25 billion capex ramp — yet the market is selling the news.
The Jobs Number Nobody Wants to Read Tomorrow
ADP missed. Vanguard’s data is worse. The Fed has nowhere to go.
China Just Weaponized Rare Earths Again. The Real Trade Is Not MP Materials.
The supply chain story Wall Street is reading wrong.
Dell Just Printed the Most Shocking AI Quarter in Hardware History
The PC maker nobody respects just posted $16.1B in AI server revenue. The backlog says the real story has not even started.
Oil Is Still the Most Important Trade in the Market
The Strait of Hormuz is still disrupted. XOM, CVX, OXY, and COP are still printing cash.
Utilities Just Got Interesting
The NEE-Dominion merger isn’t a one-off. It’s the starting gun.
The Oil Trade Is at a Crossroads — What the Iran Ceasefire Talks Mean for Energy Stocks Right Now
WTI dropped to an eight-week low on peace hopes. Here’s how traders should be thinking about positioning in the best-performing sector of 2026.
NVDA’s $81.6B Quarter and the Options Setup That Followed
Record earnings, a 25x dividend hike, and elevated IV – here’s what the tape is saying right now
Salesforce Beat the Quarter, Then the Stock Sold Off. Here’s What the Options Market Already Knew.
CRM delivered record Q1 FY2027 results powered by Agentforce — but the price action tells a more complicated story that options traders were already pricing in.